Juan Andres Moderna, Inc. (MRNA) insider trading activity

Juan Andres is Officer of Moderna, Inc.. Currently has a direct ownership of 12,803 shares of MRNA, which is worth approximately $1.02 Million. The most recent transaction as insider was on Apr 29, 2022, when has been sold 2,000 shares (Common Stock) at a price of $150.0 per share, resulting in proceeds of $300,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.8K

0% 3M change

0% 12M change

Total Value Held $1.02 Million

Juan Andres Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 29 2022	SELL Open market or private sale	$300,000 $150.0 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
Apr 29 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock
Apr 20 2022	SELL Open market or private sale	$306,000 $153.0 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
Apr 20 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock
Apr 13 2022	SELL Open market or private sale	$316,740 $158.37 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
Apr 13 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock
Apr 06 2022	SELL Open market or private sale	$315,000 $157.5 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
Apr 06 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock
Mar 30 2022	SELL Open market or private sale	$365,580 $182.79 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
Mar 30 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock
Mar 23 2022	SELL Open market or private sale	$369,320 $184.66 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
Mar 23 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock
Mar 16 2022	SELL Open market or private sale	$300,020 $150.01 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
Mar 16 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock
Mar 14 2022	SELL Open market or private sale	$300,000 $150.0 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
Mar 14 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock
Mar 02 2022	SELL Open market or private sale	$300,000 $150.0 p/Share	2,000 Reduced 18.07%	9,069 Common Stock
Mar 02 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 15.3%	11,069 Common Stock
Mar 01 2022	SELL Open market or private sale	$970,853 $152.53 p/Share	6,365 Reduced 41.24%	9,069 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	14,462 Added 48.37%	15,434 Common Stock
Feb 24 2022	SELL Open market or private sale	$300,000 $150.0 p/Share	2,000 Reduced 67.29%	972 Common Stock
Feb 24 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 40.23%	2,972 Common Stock
Feb 16 2022	SELL Open market or private sale	$300,000 $150.0 p/Share	2,000 Reduced 67.29%	972 Common Stock
Feb 16 2022	BUY Exercise of conversion of derivative security	$28,440 $14.22 p/Share	2,000 Added 40.23%	2,972 Common Stock
Feb 10 2022	SELL Open market or private sale	$122,028 $158.89 p/Share	768 Reduced 44.14%	972 Common Stock

Also insider at

AVTR

Avantor, Inc. Basic Materials

Director

EVLO

Evelo Biosciences, Inc. Healthcare

Director

Juan Andres

Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account